BioCentury | Aug 8, 2020
Translation in Brief

Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

...Phosphoinositide 3-kinase PIK3CA (p110α) - Phosphoinositide 3-kinase catalytic subunit α polypeptide PR (PGR) - Progesterone...
...p110alpha) Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) Estrogen receptor 1 (ER) (ESR1) Estrogen receptor 2 (ESR2) Progesterone...
BioCentury | Mar 13, 2020
Product Development

March 12 Quick Takes: WuXi AppTec’s Wuhan site back online; plus SOX relief, AZ, BMS, Nicox-Ocumesion, Tyligand-Context

...where Context may receive a 6% royalty. Targets PARP - Poly(ADP-ribose) polymerase PR (PGR) - Progesterone...
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

...ligand 1 PD-L2 (PDCD1LG2; B7-DC) - Programmed cell death 1 ligand 2 PGR (PR) - Progesterone...
BioCentury | Apr 22, 2019
Distillery Therapeutics

Inhibiting the LLGL2-SLC7A5-YKT6 complex for breast cancer

...LLGL2-SLC7A5-YKT6 leucine transporter complex could help treat breast cancer. In patients with estrogen receptor- and progesterone...
BioCentury | Mar 8, 2019
Company News

TNBC gets its first targeted agent with Tecentriq approval

...Epidermal growth factor receptor 2; ER - Estrogen receptor; PARP - Poly(ADP-ribose) polymerase; PR - Progesterone...
BioCentury | Feb 22, 2019
Targets & Mechanisms

Expansion into TNBC

...kinase 1 Triple-negative breast cancer (TNBC) is characterized by the absence of the estrogen receptor, progesterone...
BioCentury | Feb 8, 2019
Product R&D

Reducing R(i)SK in TNBC

...by the absence of the three most common receptors in breast cancer: estrogen receptor (ER), progesterone...
BioCentury | Oct 6, 2018
Finance

Seeking validation

...NASDAQ:SBPH) Inarigivir soproxil Chronic HBV Additional Ph II ACHIEVE data November TherapeuticsMD Inc. (NASDAQ:TXMD) TX-001HR estradiol/progesterone...
BioCentury | Aug 31, 2018
Clinical News

Allergan uterine fibroids therapy hits regulatory setback

...under a 2010 deal, markets ulipristal in Canada as Fibristal. The compound is a selective progesterone...
...Business: Genitourinary Paul Bonanos EllaOne, Esmya, Fibristal, Ulipristal, ulipristal acetate (PGL4001, cdb-2914, ella) Allergan plc Gedeon Richter plc HRA Pharma S.A. Progesterone...
BioCentury | Aug 21, 2018
Company News

Allergan uterine fibroids therapy hits regulatory setback

...under a 2010 deal, markets ulipristal in Canada as Fibristal. The compound is a selective progesterone...
Items per page:
1 - 10 of 472